Catalent Appoints Wetteny Joseph to Lead Pharma and Consumer Health
Catalent appointed Wetteny Joseph as Group President, Pharma and Consumer Health, effective 2 November 2026. He succeeds Aris Gennadios and will lead a business covering oral drug delivery and manufacturing, alongside consumer health solutions. Joseph rejoins Catalent from Zoetis, where he was Executive Vice President and Chief Financial Officer, and previously held senior finance and clinical supply leadership positions at Catalent.